These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13630699)

  • 1. Clinical study with a new hydrocholeretic drug and a new hydrocholeretic-antispasmodic combination.
    SETTEL E
    J Am Geriatr Soc; 1959 Mar; 7(3):265-7. PubMed ID: 13630699
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trial and evaluation of a new hepatoprotector, choleretic and antispasmodic preparation].
    Fernández Navarro MD; García Pérez M; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1972 Oct; 38(4):503-10. PubMed ID: 4629092
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical impressions of a new hydrocholeretic agent, zanchol.
    SCHWARTZ IR; LEHMAN E; SEIBEL JM
    Am J Gastroenterol; 1959 Jan; 31(1):28-33. PubMed ID: 13606110
    [No Abstract]   [Full Text] [Related]  

  • 4. [SIGNIFICANCE AND USES OF CHOLAGOGUE THERAPY].
    GROSSI F
    Clin Ter; 1964 Apr; 29():140-60. PubMed ID: 14163564
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of some new anthelminthic, anticholinergic, hydrocholeretic, and antispasmodic drugs.
    McHARDY G; McHARDY RJ; CRAIGHEAD C; HURST IJ; CRADIC H
    South Med J; 1959 Jan; 52(1):102-7. PubMed ID: 13624855
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cholagogic agents].
    Pasichnyk IKh
    Farm Zh; 1978; (2):39-43. PubMed ID: 658339
    [No Abstract]   [Full Text] [Related]  

  • 7. [On a combination of a synthetic choleretic and a "mixed" spasmolytic with vitamins B-I and PP, in the therapy of some hepatobiliary diseases. Clinical study].
    ABBONA C; GATTO PL
    Minerva Med; 1962 May; 53():1486-91. PubMed ID: 13858818
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-experimental study on a new substance with choleretic action (1-phenyl-1-hydroxy-n-pentane) associated with a spasmolytic having double atropine- and papaverine-like action in patients with hepatobiliary diseases].
    VANCINI B
    Minerva Med; 1962 May; 53():1478-86. PubMed ID: 13924674
    [No Abstract]   [Full Text] [Related]  

  • 9. THE EFFECT OF 10-(ALPHA-DIMETHYLAMINOPROPRIONYL) PHENOTHIAZINE METHOBROMIDE ON GASTRIC SECRETION.
    ROWE PB; FENTON B
    Am J Dig Dis; 1965 Mar; 10():205-10. PubMed ID: 14263057
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effects of drugs on extrahepatic bile ducts].
    Ritter U
    Med Klin; 1979 Jul; 74(27):1047-52. PubMed ID: 470790
    [No Abstract]   [Full Text] [Related]  

  • 11. [SOME DRUGS THAT ACT ON THE BILIARY SYSTEM].
    BENINCASA JA
    Sem Med; 1963 Jul; 123():110-3. PubMed ID: 14084464
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of certain antispasmodic drugs on the intact human colon, with special reference to banthine (beta-diethylaminoethyl xanthene-9-carboxylate methobromide).
    KERN F; ALMY TP; STOLK NJ
    Am J Med; 1951 Jul; 11(1):67-74. PubMed ID: 14837927
    [No Abstract]   [Full Text] [Related]  

  • 13. Excretion of nitrofurantoin in dog hepatic bile.
    Conklin JD; Wagner DL
    Br J Pharmacol; 1971 Sep; 43(1):140-50. PubMed ID: 5136454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Choleretic action of Vichy waters studied by stercobilin stercobilin determination].
    BONNET GF; NEPVEUX P; NEPVEUX F
    Sem Hop; 1954 Nov; 30(75):4164-9. PubMed ID: 13225816
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of methantheline (banthine) bromide in gastroenterology.
    McHARDY GG; BROWNE DC; MAREK FH; McHARDY R; WARD S
    J Am Med Assoc; 1951 Dec; 147(17):1620-6. PubMed ID: 14880413
    [No Abstract]   [Full Text] [Related]  

  • 16. Banthine in urologic disorders.
    RISKIND LA; ZIDE HA
    J Urol; 1952 Sep; 68(3):636-7. PubMed ID: 12991363
    [No Abstract]   [Full Text] [Related]  

  • 17. [The "cholereticmorphine" test. Its value in diseases of the biliary tract and in migraines].
    DEBRAY C; HARDOUIN JP; FABLET J
    Gastroenterologia; 1962; 97():137-48. PubMed ID: 13884678
    [No Abstract]   [Full Text] [Related]  

  • 18. [Present status of cholagogue and choleretic medication in biliary disorders].
    DEBRAY C; HARDOUIN JP
    Rev Prat; 1962 Feb; 12():596-9. PubMed ID: 13884680
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of drugs on galvanic skin resistance; comparison of methantheline, propantheline, and a placebo.
    PERRY DJ; MOUNT GE; HULL C
    AMA Arch Derm; 1955 Apr; 71(4):476-7. PubMed ID: 14360759
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of physical exercise during drug therapy of chronic cholecystoangiocholitis (clinicophysiological study)].
    Ragimov DM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(6):518-21. PubMed ID: 5515370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.